Author:
Brastianos Priscilla K,Horowitz Peleg M,Santagata Sandro,Jones Robert T,McKenna Aaron,Getz Gad,Ligon Keith L,Palescandolo Emanuele,Van Hummelen Paul,Ducar Matthew D,Raza Alina,Sunkavalli Ashwini,MacConaill Laura E,Stemmer-Rachamimov Anat O,Louis David N,Hahn William C,Dunn Ian F,Beroukhim Rameen
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Choy, W. et al. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg. Focus 30, E6 (2011).
2. van Alkemade, H. et al. Impaired survival and long-term neurological problems in benign meningioma. Neuro-oncol. 14, 658–666 (2012).
3. Durand, A. et al. WHO grade II and III meningiomas: a study of prognostic factors. J. Neurooncol. 95, 367–375 (2009).
4. Perry, A., Scheithauer, B.W., Stafford, S.L., Lohse, C.M. & Wollan, P.C. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85, 2046–2056 (1999).
5. Goutagny, S. et al. Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin. Cancer Res. 16, 4155–4164 (2010).
Cited by
540 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献